Murine Anti-NY-ESO-1 T Cell Receptors
European Patent
20201340.5
Filed on 2020-10-12
20201340.5
Filed on 2020-10-12
3-O-SULFO-GALACTOSYLCERAMIDE ANALOGS AS ACTIVATORS OF TYPE II NKT CELLS AND USES THEREOF
US Patent 12,268,700
Filed on 2020-09-25
Filed on 2020-09-25
3-O-SULFO-GALACTOSYLCERAMIDE ANALOGS AS ACTIVATORS OF
TYPE II NKT CELLS AND USES THEREOF
European Patent
19716658.0
Filed on 2020-10-07
19716658.0
Filed on 2020-10-07
Methodology For Astatination And Radioiodination Based On Iodonium Salt Precursors
US Patent 10,858,306
Filed on 2020-04-09
Filed on 2020-04-09
Methods of Preparing Anti-human Papillomavirus Antigen T Cells
Australia
2020233702
Filed on 2020-09-16
2020233702
Filed on 2020-09-16
MODIFIED CELLS AND METHODS OF THERAPY
US Patent 11,583,556
Filed on 2020-08-26
Filed on 2020-08-26
METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF
US Patent 12,415,845
Filed on 2020-10-23
Filed on 2020-10-23
METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF
Japan
2020-559481
Filed on 2020-10-23
2020-559481
Filed on 2020-10-23
METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF
European Patent
19726230.6
Filed on 2020-11-03
19726230.6
Filed on 2020-11-03